What Sets Us Apart
“We believe StemCells Inc. is the most advanced company in the next generation of stem cell therapies.” 1
Stephen M. Dunn
President & Senior Managing Director of Research, LifeTech Capital
Scientific and Business Leadership
Credited with significant breakthroughs in the field, our distinguished team includes internationally renowned experts in the fields of stem cell biology, biotechnology, regenerative medicine and cGMP manufacturing working alongside our accomplished business leaders to realize the great promise of stem cell technology.
Learn more about our People and our Science…
Broad Therapeutic Pipeline – Multi-organ Focus
Our therapeutic product development programs target diseases of major organ systems including both the central nervous system (CNS) and the liver. Our broad pipeline is addressing disorders in all three regions of the CNS – the brain, the spinal cord and the eye, along with a variety of liver diseases.
Learn more about our Therapeutic Programs…
Pioneering Clinical Translation for CNS Disorders
Our CNS Program is the most advanced neural stem cell clinical development program in the field. As the first ever to conduct a US clinical trial with human neural stem cells, and the only company to date with established human safety data for these cells, we are poised to be among the first to market a stem cell-based therapeutic product for CNS disorders.
Learn more about our Clinical Trials…
Homologous Approach Using Tissue-Derived “Adult” Stem Cells
We are primarily focused on the use of tissue-derived “adult” cells for use in homologous therapy (e.g. the use of CNS-derived neural stem cells for the treatment of CNS disorders and liver-derived cells for the treatment of liver disorders). Unlike embryonic or induced pluripotent stem (iPS) cells, tissue-derived stem cells need not be modified in any way before transplantation.
Learn more about our Approach…
Strong Intellectual Property Position
Our comprehensive IP portfolio is among the broadest and deepest in the field, and includes an unparalleled leadership in human neural stem cell technology.
Learn more about our Intellectual Property…
“One-Stop Shop” Drug Discovery Platform
Our core capabilities and broad array of enabling tools and technologies address the entire life cycle of drug discovery and development, from compound screening and in vitro characterization through in vivo validation of lead candidates using the actual human target cell.
Learn more about our Drug Discovery & Development Platform…
Growing Research Products Business
Our SC Proven® products enable leading-edge stem cell research around the globe.
Learn more about our SC Proven Products…